NP Life Sciences Health Industry Group Inc. (ACAT) stock
ACATOTCServices-Educational ServicesFiscal year ends December 31
Financials through Q4 FY2023, quarter ended Dec 31, 2023Last filing: 10-K on Apr 16, 2024
$10.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $429.60MP/E –Yield –
NP Life Sciences Health Industry EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
NP Life Sciences Health Industry's EPS for the twelve months ending Dec 31, 2023 was $0.00. For fiscal 2023 it was $0.00. The highest annual figure on record is $0.00 in fiscal 2019.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0.00 | – |
| FY2022 | Dec 31, 2022 | $0.00 | – |
| FY2021 | Dec 31, 2021 | $0.00 | – |
| FY2020 | Dec 31, 2020 | $0.00 | – |
| FY2019 | Dec 31, 2019 | $0.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0.00 | – |
| Q3 FY2023 | Sep 30, 2023 | $0.00 | – |
| Q2 FY2023 | Jun 30, 2023 | $0.00 | – |
| Q1 FY2023 | Mar 31, 2023 | $0.00 | – |
| Q4 FY2022 | Dec 31, 2022 | $0.00 | – |
| Q3 FY2022 | Sep 30, 2022 | $0.00 | – |
| Q2 FY2022 | Jun 30, 2022 | $0.00 | – |
| Q1 FY2022 | Mar 31, 2022 | $0.00 | – |
| Q4 FY2021 | Dec 31, 2021 | $0.00 | – |
| Q3 FY2021 | Sep 30, 2021 | $0.00 | – |
| Q2 FY2021 | Jun 30, 2021 | $0.00 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.00 | – |
| Q4 FY2020 | Dec 31, 2020 | $0.00 | – |
| Q3 FY2020 | Sep 30, 2020 | $0.00 | – |
| Q2 FY2020 | Jun 30, 2020 | $0.00 | – |
| Q1 FY2020 | Mar 31, 2020 | $0.00 | – |
| Q4 FY2019 | Dec 31, 2019 | $0.00 | – |
| Q3 FY2019 | Sep 30, 2019 | $0.00 | – |
| Q2 FY2019 | Jun 30, 2019 | $0.00 | – |
| Q1 FY2019 | Mar 31, 2019 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?